Sun, Jun http://orcid.org/0000-0001-9099-1829
Shin, Dong Yeon
Eiseman, Mark
Yallowitz, Alisha R.
Li, Na
Lalani, Sarfaraz
Li, Zan http://orcid.org/0000-0002-4873-4471
Cung, Michelle http://orcid.org/0000-0002-2457-4266
Bok, Seoyeon http://orcid.org/0000-0001-6063-1224
Debnath, Shawon
Marquez, Sofia Jenia
White, Tommy E.
Khan, Abdul G.
Lorenz, Ivo C. http://orcid.org/0000-0002-7373-1176
Shim, Jae-Hyuck http://orcid.org/0000-0002-4947-3293
Lee, Francis S. http://orcid.org/0000-0002-7108-9650
Xu, Ren
Greenblatt, Matthew B. http://orcid.org/0000-0001-9794-8532
Article History
Received: 9 July 2020
Accepted: 9 July 2021
First Online: 29 July 2021
Competing interests
: J.H.S. is a scientific co-founder of AAVAA therapeutics and holds equity in this company. The remaining authors declare no competing interests.